Virulence 2010, 1:359–366.PubMedCrossRef 4. Hamza OJM, Matee MI, Moshi MJ, Simon EN, Mugusi F, Mikx FH, Heldermana WH, Rijs AJ, van Lorlatinib in vivo der Ven AJ, Verweij PE: Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV infected patients with primary and recurrent oropharyngeal candidiasis. BMC Microbiology 2008, 8:135.PubMedCrossRef 5. Silva S, Henriques M, Oliveira R, Williams D, Azeredo J: In vitro biofilm activity of non- Candida

albicans Candida species. Current Microbiology 2010, 61:534–540.PubMedCrossRef 6. Silva S, Negri M, Henriques M, Oliveira R, Williams D, Azeredo J: Silicone colonization by non- Candida albicans Candida species in the presence of urine. Journal of Medical Microbiology 2010, 59:747–754.PubMedCrossRef 7. Noumi E, Snoussi M, Hentati H, Mahdouani K, del Castillo L, Valentin E, Sentandreu R, Bakhrouf A: Adhesive properties and hydrolytic enzymes of oral Candida albicans strains. Mycopathologia 2010, 169:269–278.PubMedCrossRef 8. Nobile CJ, Nett JE, Andes DR, Mitchell AP: Function of Candida albicans adhesion Hwp1 in biofilm formation. Eukaryotic Cell 2006, 5:1604–1610.PubMedCrossRef 9. Seneviratne CJ, Silva WJ, Jin LJ, Samaranayake YH, Samaranayake LP: Architectural analysis, viability assessment and CHIR98014 growth kinetics of Candida albicans and Candida glabrata biofilms. Archives of Oral Biology 2009, 54:1052–1060.PubMedCrossRef 10. Chamilos G, Lionakis MS, Lewis RE,

Kontoyiannis DP: Role of mini-host models in the study of medically important fungi. Lancet Infectious Diseases 2007, 7:42–55.PubMedCrossRef 11. Mylonakis E, Aballay A: Worms and flies as genetically tractable animal models to study host-pathogen interactions. Infection and Immunity 2005, 73:3833–3841.PubMedCrossRef 12. Fuchs BB, Mylonakis E: Using non-mammalian hosts to study fungal virulence and host defense. Current Opinion in Microbiology 2006, 9:346–351.PubMedCrossRef 13. Mylonakis E: Galleria mellonella and the study of fungal pathogenesis: making the case for another genetically tractable model host. Mycopathologia 2008, 165:1–3.PubMedCrossRef 14. Bergin D, Murphy L, Keenan J, Clynes M, Kavanagh K: Pre-expose of yeast

protects larvae of Galleria mellonella from a subsequent lethal infection by Candida albicans and is mediated by the increased expression of antimicrobial TCL SAHA HDAC molecular weight peptides. Microbes and Infection 2006, 8:2105–2112.PubMedCrossRef 15. Rowan R, Moran C, McCann M, Kavanagh K: Use of Galleria mellonella larvae to evaluate the in vivo anti-fungal activity of [Ag 2 (mal)(phen) 3 ]. Biometals 2009, 22:461–467.PubMedCrossRef 16. Mowlds P, Kavanagh K: Effect of pre-incubation temperature on susceptibility of Galleria mellonella larvae to infection by Candida albicans . Mycopathologia 2008, 165:5–12.PubMedCrossRef 17. Fuchs BB, Eby J, Nobile CJ, El Khoury JB, Mitchell AP, Mylonakis E: Role of filamentation in Galleria mellonella killing by Candida albicans .